» Articles » PMID: 32312235

Treatment with Radiosynoviorthesis in Hemophilic Patients with and Without Inhibitor

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2020 Apr 22
PMID 32312235
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spontaneous bleedings occurring into joints (hemarthrosis) are the most common manifestations of hemophilia and causes severe joint damage ultimately resulting in joint disfunction known as hemophilic arthropathy. Among available therapeutic options for reducing recurrent hemarthrosis-associated damage, radiosynoviorthesis (RS) has proven effective in improving joint function.

Aim: To assess the impact of RS with Yttrium(90) citrate (C-Y(90)) on frequency of hemarthroses and joint function in a group of pediatric patients.

Methods: Between November 1998 and February 2017, we evaluated 27 pediatric patients with mild, moderate or severe hemophilia with haemophilic arthropathy. Overall, RS was applied in 60 joints. Some patients received more than one single intra-articular injection with C-Y(90).

Results: During the follow-up, one patient showed joint bleeding 15 months after RS, one patient after 12 months and one patient after 45 days. The episodes of hemarthrosis were reduced and joint function significantly improved in all patients.

Conclusion: RS with C-Y(90) is a simple and safe treatment for reducing the frequency of hemarthroses in patients with hemophilia. It decreases the use of factor VIII / IX and improves joint function.

Citing Articles

Cartilage Destruction by Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway in Human Chondrocytes.

Wagener N, Hardt S, Pumberger M, Schomig F J Clin Med. 2024; 13(2).

PMID: 38256694 PMC: 10816407. DOI: 10.3390/jcm13020559.


The EANM guideline for radiosynoviorthesis.

Kampen W, Boddenberg-Patzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M Eur J Nucl Med Mol Imaging. 2021; 49(2):681-708.

PMID: 34671820 PMC: 8803784. DOI: 10.1007/s00259-021-05541-7.


Orthopedic surgery in hemophilic patients with musculoskeletal disorders: A systematic review.

Badulescu O, Sirbu P, Ungureanu C, Pnzariu A, Cojocaru E, Filip N Exp Ther Med. 2021; 22(3):995.

PMID: 34345277 PMC: 8311230. DOI: 10.3892/etm.2021.10427.

References
1.
Kavakli K, Aydogdu S, Taner M, Duman Y, Balkan C, Karapinar D . Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders. Haemophilia. 2008; 14(3):518-23. DOI: 10.1111/j.1365-2516.2008.01691.x. View

2.
Mannucci P, Tuddenham E . The hemophilias--from royal genes to gene therapy. N Engl J Med. 2001; 344(23):1773-9. DOI: 10.1056/NEJM200106073442307. View

3.
Heuft-Dorenbosch L, de Vet H, van der Linden S . Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review. Ann Rheum Dis. 2000; 59(8):583-6. PMC: 1753206. DOI: 10.1136/ard.59.8.583. View

4.
Vuorela J, Sokka T, Pukkala E, Hannonen P . Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis?. Ann Rheum Dis. 2003; 62(3):251-3. PMC: 1754477. DOI: 10.1136/ard.62.3.251. View

5.
Coppola A, Franchini M . Target of prophylaxis in severe haemophilia: more than factor levels. Blood Transfus. 2013; 11(3):327-9. PMC: 3729119. DOI: 10.2450/2012.0244-12. View